BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 98619)

  • 1. In vivo distribution of carbon-11 phenytoin and its major metabolite, and their use in scintigraphic imaging.
    Stavchansky SA; Tilbury RS; McDonald JM; Ting CT; Kostenbauder HB
    J Nucl Med; 1978 Aug; 19(8):936-41. PubMed ID: 98619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary excretion of diphenylhydantoin in the rat. Time-course studies.
    Inaba T; Umeda T
    Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin metabolism in mice.
    Chow SA; Fischer LJ
    Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of estradiol-17 beta treatment on the metabolism and biliary excretion of phenytoin in the isolated perfused rat liver and in vivo.
    Vore M; Montgomery C
    J Pharmacol Exp Ther; 1980 Oct; 215(1):71-6. PubMed ID: 7452491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of chemical structure and solvent to in vivo scintigraphic distribution patterns of 11C compounds. II. 11C aminonitriles.
    Winstead MB; Widner PJ; Means JL; Engstrom MA; Graham GE; Khentigan A; Lin TH; Lamb JF; Winchell HS
    J Nucl Med; 1975 Nov; 16(11):1049-57. PubMed ID: 1185267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pregnancy on the biliary excretion of [14C]phenytoin in the rat.
    Vore M; Soliven E; Blunden M
    J Pharmacol Exp Ther; 1979 Feb; 208(2):257-62. PubMed ID: 762658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of 14C-, 125I-, and 131I-diphenylhydantoin in the toadfish, rat, and human with insulinomas.
    Balachandran S; Beierwaltes WH; Ice RD; Fajans SS; Ryo UY; Redmond MJ; Hetzel KR; Mosley ST; Feldstein B
    J Nucl Med; 1975 Aug; 16(8):775-9. PubMed ID: 170386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
    Buttar HS
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin.
    Ohnmacht CM; Chen S; Tong Z; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):83-91. PubMed ID: 16621742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of brain and whole-body pharmacokinetics of 11C-labeled diphenylhydantoin in rats by means of planar positron imaging system.
    Hasegawa Y; Kanai Y; Hasegawa S; Okamoto T; Matsui T; Shimosegawa E; Kurachi Y; Hatazawa J
    Ann Nucl Med; 2008 May; 22(4):301-7. PubMed ID: 18535881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxyl-labeled 11C-1-aminocyclopentanecarboxylic acid, a potential agent for cancer detection.
    Hayes RL; Washburn LC; Wieland BW; Sun TT; Turtle RR; Butler TA
    J Nucl Med; 1976 Aug; 17(8):748-51. PubMed ID: 180270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
    J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of chemical structure to in vivo scintigraphic distribution patterns of 11C compounds. I. 11C-carboxylates.
    Winstead MB; Lamb JF; Winchell HS
    J Nucl Med; 1973 Oct; 14(10):747-54. PubMed ID: 4743582
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo distribution and identification of 11C-activity after injection of [methyl-11C]thymidine in Wistar rats.
    Goethals P; van Eijkeren M; Lemahieu I
    J Nucl Med; 1999 Mar; 40(3):491-6. PubMed ID: 10086716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat.
    El-Hawari AM; Plaa GL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.
    Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM
    Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.